SAN CLEMENTE, Calif., Feb. 28, 2012 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical devices used in infusion therapy, oncology and critical care applications, today announced that Company management will present at the following two investor conferences:

• The 24^th Annual ROTH Conference to be held on March 11-14 at the Ritz Carlton Laguna Niguel in Dana Point, CA. The presentation will take place on Monday, March 12, at 8:30 AM Pacific Time. 
• The Barclays Capital 2012 Global Healthcare Conference to be held on March 13-15 at the Loews Miami Hotel in Miami, FL. The presentation will take place on Wednesday, March 14, at 3:15 PM Eastern Time.

Both presentations will be webcast live and can be accessed by going to the Company's website at http://www.icumed.com, clicking on the Investors tab, clicking on the Webcast icon and following the prompts. The webcast will also be available by replay.

A copy of the slides to be presented may be found by going to the Company's website at http://www.icumed.com, clicking on the Investors tab, clicking on Presentations and clicking on the March 2012 Investor Presentation.

About ICU Medical, Inc.

ICU Medical, Inc. (Nasdaq:ICUI) develops, manufactures and sells innovative medical devices used in infusion therapy, oncology, and critical care applications. ICU Medical's products improve patient outcomes by helping prevent bloodstream infections and protecting healthcare workers from exposure to infectious diseases or hazardous drugs. The Company's complete product line includes custom I.V. systems, closed delivery systems for hazardous drugs, needlefree I.V. connectors, catheters and cardiac monitoring systems. ICU Medical is headquartered in San Clemente, California. For more information, visit the Company's website at www.icumed.com.